Clinical Report: How Methodological Flaws Distorted a Decade of Serum SERS Studies

Overview

This report highlights significant methodological flaws in serum SERS studies that have led to misinterpretations of spectral data. The findings emphasize that uric acid and hypoxanthine are the primary contributors to serum SERS spectra, challenging the validity of numerous prior studies.

Background

Surface-enhanced Raman spectroscopy (SERS) has emerged as a promising tool for disease diagnosis using serum and plasma samples. However, the reliability of spectral data interpretation is crucial for clinical applications, as incorrect assignments can lead to misleading conclusions. Understanding the true molecular origins of SERS spectra is essential for advancing this technology in diagnostic settings.

Data Highlights

No numerical data available in the article.

Key Findings

• Uric acid and hypoxanthine dominate the spectral profiles in serum SERS studies.
• Many published studies misinterpret spectral data due to methodological flaws.
• Direct comparisons and spiking experiments confirmed the dominance of uric acid and hypoxanthine in serum spectra.
• Depletion of uric acid from serum significantly altered the spectral output, reinforcing its primary role.
• Analysis of serum from 81 donors confirmed that detectable bands were consistently attributed to uric acid and hypoxanthine.

Clinical Implications

Clinicians should be cautious when interpreting SERS data from serum analyses, as many studies may be based on flawed methodologies. A clear understanding of the spectral contributions is necessary for the potential clinical application of SERS in diagnostics.

Conclusion

The identification of methodological flaws in serum SERS studies underscores the need for rigorous validation of spectral interpretations. This clarity is vital for the future application of SERS in clinical diagnostics.

References

1. American Journal of Epidemiology, 2023 -- The Effects of Statistical Corrections for Assay Performance on Conclusions Drawn from SARS-CoV-2 Serological Surveillance Research
2. the analytical scientist, 2023 -- Antibody Oxidation’s Hidden Handedness Comes Into View
3. Open Forum Infectious Diseases, 2023 -- Evaluation of SARS-CoV-2 Antibody Seroprevalence Induced by Infection in Diverse Residual Blood Samples from Donors, Commercial Labs, and Health Screenings in Japan, 2023
4. the analytical scientist, 2023 -- SORS Identifies Preservation Fluids Through Sealed Museum Jars
5. The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence | Nature Medicine, 2023
6. Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment - PMC, 2023
7. The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence | Nature Medicine
8. Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment - PMC
9. CLSI PRE02
10. Raman spectroscopy in the detection and diagnosis of lung cancer: a meta-analysis - PMC